SG11201600484TA - Methods for improving asthma symptoms using benralizumab - Google Patents
Methods for improving asthma symptoms using benralizumabInfo
- Publication number
- SG11201600484TA SG11201600484TA SG11201600484TA SG11201600484TA SG11201600484TA SG 11201600484T A SG11201600484T A SG 11201600484TA SG 11201600484T A SG11201600484T A SG 11201600484TA SG 11201600484T A SG11201600484T A SG 11201600484TA SG 11201600484T A SG11201600484T A SG 11201600484TA
- Authority
- SG
- Singapore
- Prior art keywords
- benralizumab
- methods
- asthma symptoms
- improving asthma
- improving
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361864950P | 2013-08-12 | 2013-08-12 | |
| PCT/US2014/050122 WO2015023508A2 (fr) | 2013-08-12 | 2014-08-07 | Procédés permettant d'améliorer les symptômes de l'asthme au moyen de benralizumab |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201600484TA true SG11201600484TA (en) | 2016-02-26 |
Family
ID=52448839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201600484TA SG11201600484TA (en) | 2013-08-12 | 2014-08-07 | Methods for improving asthma symptoms using benralizumab |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9441047B2 (fr) |
| EP (3) | EP3988114A1 (fr) |
| JP (2) | JP6803229B2 (fr) |
| KR (1) | KR102337601B1 (fr) |
| CN (2) | CN111617244A (fr) |
| AU (3) | AU2014306960B2 (fr) |
| BR (1) | BR112016002462A8 (fr) |
| CA (1) | CA2918050C (fr) |
| DK (2) | DK3033103T3 (fr) |
| ES (2) | ES2901634T3 (fr) |
| HK (2) | HK1221647A1 (fr) |
| HU (2) | HUE057065T2 (fr) |
| MX (1) | MX368474B (fr) |
| PL (2) | PL3536339T3 (fr) |
| RU (2) | RU2728578C2 (fr) |
| SG (1) | SG11201600484TA (fr) |
| TR (1) | TR201910413T4 (fr) |
| WO (1) | WO2015023508A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3875487A1 (fr) * | 2013-08-12 | 2021-09-08 | Astrazeneca AB | Procédé pour augmenter le volume d'expiration forcée chez des asthmatiques à l'aide de benralizumab |
| AU2014306956B2 (en) | 2013-08-12 | 2019-11-21 | Astrazeneca Ab | Methods for reducing exacerbation rates of asthma using benralizumab |
| US20150104447A1 (en) * | 2013-10-15 | 2015-04-16 | Medimmune, Llc | Methods for treating chronic obstructive pulmonary disease using benralizumab |
| WO2017077391A2 (fr) | 2015-11-04 | 2017-05-11 | Astrazeneca Ab | Dipeptidyl peptidase-4 et périostine utilisées comme prédicteurs d'une réponse clinique à des agents thérapeutiques ciblés sur les éosinophiles dans des maladies éosinophiles |
| US20180056018A1 (en) * | 2016-08-31 | 2018-03-01 | Cephalon, Inc. | Inhalation Systems, Devices and Methods |
| TW202214692A (zh) * | 2020-06-05 | 2022-04-16 | 瑞典商阿斯特捷利康公司 | 治療患有鼻瘜肉的患者的重度氣喘之方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2233974T3 (es) | 1995-09-11 | 2005-06-16 | Kyowa Hakko Kogyo Co., Ltd. | Anticuerpo contra la cadena alfa del receptor de la interleucina 5 humana. |
| US6746839B1 (en) * | 1998-01-12 | 2004-06-08 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for an obstructive airway disease |
| ES2571230T3 (es) | 1999-04-09 | 2016-05-24 | Kyowa Hakko Kirin Co Ltd | Procedimiento para controlar la actividad de una molécula inmunofuncional |
| EP1266663A4 (fr) | 2000-02-15 | 2003-07-23 | Kyowa Hakko Kogyo Kk | Inducteur de l'apoptose specifique a l'eosinophilie |
| US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| US8093357B2 (en) | 2002-03-01 | 2012-01-10 | Xencor, Inc. | Optimized Fc variants and methods for their generation |
| WO2005035583A1 (fr) | 2003-10-08 | 2005-04-21 | Kyowa Hakko Kogyo Co., Ltd. | Composition d'anticorps se liant specifiquement au recepteur il-5 |
| US20060014680A1 (en) | 2004-07-13 | 2006-01-19 | Caiding Xu | Peptides and compounds that bind to the IL-5 receptor |
| WO2007041635A2 (fr) | 2005-10-03 | 2007-04-12 | Xencor, Inc. | Variants de fc dotés de propriétés de liaison aux récepteurs fc optimisées |
| JP2010527356A (ja) * | 2007-05-14 | 2010-08-12 | メディミューン，エルエルシー | 好酸球レベルを低下させる方法 |
| EP3447491A3 (fr) * | 2010-12-16 | 2019-06-05 | F. Hoffmann-La Roche AG | Diagnostic et traitements associés à l'inhibition de th2 |
| WO2012158954A1 (fr) | 2011-05-18 | 2012-11-22 | Medimmune, Llc | Méthodes de diagnostic et de traitement de maladies ou affections pulmonaires |
| US20140328839A1 (en) | 2011-11-01 | 2014-11-06 | Medlmmune, Llc | Methods For Reducing The Frequency And Severity Of Acute Exacerbations Of Asthma |
| AU2014306956B2 (en) * | 2013-08-12 | 2019-11-21 | Astrazeneca Ab | Methods for reducing exacerbation rates of asthma using benralizumab |
| EP3875487A1 (fr) * | 2013-08-12 | 2021-09-08 | Astrazeneca AB | Procédé pour augmenter le volume d'expiration forcée chez des asthmatiques à l'aide de benralizumab |
-
2014
- 2014-08-07 KR KR1020167006565A patent/KR102337601B1/ko active IP Right Grant
- 2014-08-07 JP JP2016534616A patent/JP6803229B2/ja active Active
- 2014-08-07 CN CN202010449449.1A patent/CN111617244A/zh active Pending
- 2014-08-07 US US14/454,149 patent/US9441047B2/en active Active
- 2014-08-07 HU HUE19162585A patent/HUE057065T2/hu unknown
- 2014-08-07 PL PL19162585T patent/PL3536339T3/pl unknown
- 2014-08-07 MX MX2016001195A patent/MX368474B/es active IP Right Grant
- 2014-08-07 AU AU2014306960A patent/AU2014306960B2/en active Active
- 2014-08-07 WO PCT/US2014/050122 patent/WO2015023508A2/fr active Application Filing
- 2014-08-07 EP EP21188229.5A patent/EP3988114A1/fr not_active Withdrawn
- 2014-08-07 TR TR2019/10413T patent/TR201910413T4/tr unknown
- 2014-08-07 EP EP14836392.2A patent/EP3033103B1/fr active Active
- 2014-08-07 DK DK14836392.2T patent/DK3033103T3/da active
- 2014-08-07 RU RU2016108734A patent/RU2728578C2/ru active
- 2014-08-07 CN CN201480044052.7A patent/CN105451761A/zh active Pending
- 2014-08-07 SG SG11201600484TA patent/SG11201600484TA/en unknown
- 2014-08-07 ES ES19162585T patent/ES2901634T3/es active Active
- 2014-08-07 CA CA2918050A patent/CA2918050C/fr active Active
- 2014-08-07 DK DK19162585.4T patent/DK3536339T3/da active
- 2014-08-07 HU HUE14836392A patent/HUE045402T2/hu unknown
- 2014-08-07 PL PL14836392T patent/PL3033103T3/pl unknown
- 2014-08-07 RU RU2020123894A patent/RU2020123894A/ru unknown
- 2014-08-07 BR BR112016002462A patent/BR112016002462A8/pt not_active Application Discontinuation
- 2014-08-07 EP EP19162585.4A patent/EP3536339B1/fr active Active
- 2014-08-07 ES ES14836392T patent/ES2740355T3/es active Active
-
2016
- 2016-08-16 HK HK16109789.8A patent/HK1221647A1/zh unknown
- 2016-12-01 HK HK16113685A patent/HK1225303A1/zh unknown
-
2020
- 2020-02-28 JP JP2020032499A patent/JP2020100653A/ja not_active Withdrawn
- 2020-04-16 AU AU2020202564A patent/AU2020202564A1/en not_active Abandoned
-
2023
- 2023-08-10 AU AU2023214323A patent/AU2023214323A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1250690A1 (zh) | 方法 | |
| HK1208363A1 (en) | New methods | |
| HRP20190405T1 (hr) | Postupci za smanjenje brzine pogoršanja astme korištenjem benralizumaba | |
| HUE038344T2 (hu) | Eljárás szénhidrogének elõállítására | |
| HK1225303A1 (zh) | 使用貝那利珠單抗改善哮喘症狀的方法 | |
| EP2925877A4 (fr) | Procédé de broyage | |
| EP2925876A4 (fr) | Procédé de broyage | |
| GB201700075D0 (en) | Methods to reduce gas carry-uder for cyclonic seperators | |
| GB2507760B (en) | Methods | |
| GB201219816D0 (en) | Improving local context search results | |
| GB201208874D0 (en) | Methods | |
| EP2925790A4 (fr) | Procédé de broyage | |
| EP2946008A4 (fr) | Méthodes de mobilisation de cellules souches hématopoïétiques | |
| GB201204280D0 (en) | Methods | |
| EP2964773A4 (fr) | Procédé de broyage | |
| EP2872212A4 (fr) | Procédés d'amélioration de la fertilité masculine | |
| GB201316651D0 (en) | Asthma | |
| GB201208756D0 (en) | Methods | |
| IL236547B (en) | Methods to improve male fertility | |
| GB201220686D0 (en) | Methods | |
| AP2012000550S (en) | E-horn methods | |
| GB201216074D0 (en) | Methods | |
| GB201209689D0 (en) | Methods | |
| GB201208875D0 (en) | Methods | |
| GB201208963D0 (en) | Methods |